Amazon, Axon Enterprise, Google, Meta and Oracle backed expanding electronic prior authorization to self-funded employer ...

In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, ...

Throwing more money at SDoH programs isn’t going to magically fix them. Instead, plans should be focusing on building out ...

Alcon’s Neurotech Pharmaceuticals acquisition brings the rare vision disorder cell therapy Encelto as well as the platform ...

GSK’s Hibsago brings a new mechanism of action to chronic hepatitis B, targeting the genetic instructions the virus uses to ...

MedCity News has long covered innovation in healthcare. We have also hosted events bringing together investors, startups and the healthcare ecosystem in a bid to connect those novel companies to ...

The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular ...

City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah ...

Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or ...

A new report on third quarter M&A activity in the healthcare sector found that this quarter’s hospital and health system ...